Stephen George Dilly
Director, AVIGEN INC \DE.
Companies
- CodexisOfficer Aug 3, 2022 to now1
- CodexisBoard member Jun 16, 2020 to now2
- Sierra Oncology, Inc.Board member Jun 2, 2020 to Jul 1, 20223
- Sierra Oncology, Inc.Chief executive officer Jun 2, 2020 to Jul 1, 20223
- Sierra Oncology, Inc.President Jun 2, 2020 to Jul 1, 20223
- SANGAMO THERAPEUTICS, INCBoard member Apr 2, 2010 to Jun 3, 20204
- Aimmune Therapeutics (United Kingdom)Board member Aug 5, 2015 to Jun 13, 20185
- Aimmune Therapeutics (United Kingdom)Chief executive officer Aug 5, 2015 to Jun 13, 20185
- Aimmune Therapeutics (United Kingdom)President Aug 5, 2015 to Jun 13, 20185
- Aimmune Therapeutics (United Kingdom)Officer Feb 26, 2016 to Jun 5, 20186
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Codexis CDXS727,053 shares7$901.5K at $1.24Nov 11, 2025- Sierra Oncology, Inc.0 shares8Jul 1, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 11, 2025Granted 50,000 shares at $1.85 of Codexis7
- Feb 5, 2025Granted 88,750 shares of Codexis9
- Jan 1, 2024Granted 143,425 shares of Codexis10
- Sep 8, 2023Bought 58,479 shares at $1.73 of Codexis11
- Mar 8, 2023Sold 26,987 shares at $4.56 of Codexis12
- Mar 7, 2023Sold 28,088 shares at $4.60 of Codexis12
- Feb 21, 2023Granted 112,500 shares of Codexis13
- Feb 8, 2023Granted 289,000 shares of Codexis12
- Jul 1, 2022Returned to company 5,000 shares at $55.00 of Sierra Oncology, Inc.8
- Jun 14, 2022Granted 11,273 shares of Codexis14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCodexis, Officer
- 2SEC EDGARCodexis, Board member
- 3SEC EDGARSierra Oncology, Inc., Board member
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Feb 7, 2025
- 10SEC EDGARForm 4 filed Jan 2, 2024
- 11SEC EDGARForm 4 filed Sep 12, 2023
- 12SEC EDGARForm 4 filed Mar 9, 2023
- 13SEC EDGARForm 4 filed Feb 21, 2023
- 14SEC EDGARForm 4 filed Jun 16, 2022